Entity Wide Disclosures

3 Months Ended

Mar. 31, 2018

Revenue From Contract With Customer [Abstract]

Entity Wide Disclosure

(13) Entity Wide Disclosures

Revenue by Category

The following table disaggregates our revenue by major source (in thousands):

	Three months Ended March 31, 2018
Therapeutic Area
Oncology	$	43,853
Metabolic		22,055
Cardiology		23,736
AVAI		16,679
Endocrine		6,458
Central Nervous System		13,165
Medical Devices		2,914
Other		34,217
Total Revenue	$	163,077